TipRanks
Go Ultimate55% OFF

Entia Biosciences (ERGO) Financial Statements

Entia Biosciences Financial Overview

Entia Biosciences's market cap is currently $33.66K. The company's EPS TTM is $-0.05; its P/E ratio is -0.02; Entia Biosciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ 0.00$ 0.00$ 0.00$ 0.00
EBITDA$ 0.00$ 0.00$ 0.00$ 0.00
Net Income$ 0.00$ 0.00$ 0.00$ 0.00
Balance Sheet
Cash & Short-Term Investments$ 0.00$ 0.00$ 0.00$ 0.00
Total Assets$ 0.00$ 0.00$ 0.00$ 0.00
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 0.00$ 0.00$ 0.00$ 0.00
Total Liabilities$ 0.00$ 0.00$ 0.00$ 0.00
Stockholders' Equity$ 0.00$ 0.00$ 0.00$ 0.00
Cash Flow
Free Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00
Operating Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00

Currency in USD

Entia Biosciences Earnings and Revenue History

01230 %0.4 %0.8 %1.2 %EarningsProfit Margin2019202020212022RevenueEarningsProfit Margin

Entia Biosciences Debt to Assets

01230 %0.4 %0.8 %1.2 %LiabilitiesDebt to Assets2019202020212022AssetsLiabilitiesDebt to Assets

Entia Biosciences Cash Flow

02019202020212022OperatingInvestingFinancing

Entia Biosciences Forecast EPS vs Actual EPS